197 related articles for article (PubMed ID: 11393125)
1. First-trimester Down's syndrome screening by fetal nuchal translucency measurement in Taiwan.
Jou HJ; Shih JC; Wu SC; Li TC; Tzeng CY; Hsieh FJ
J Formos Med Assoc; 2001 Apr; 100(4):257-61. PubMed ID: 11393125
[TBL] [Abstract][Full Text] [Related]
2. Combined measurement of fetal nuchal translucency, maternal serum free beta-hCG, and pregnancy-associated plasma protein A for first-trimester Down's syndrome screening.
Tsai MS; Huang YY; Hwa KY; Cheng CC; Lee FK
J Formos Med Assoc; 2001 May; 100(5):319-25. PubMed ID: 11432311
[TBL] [Abstract][Full Text] [Related]
3. Screening for Down's syndrome by fetal nuchal translucency measurement in a general obstetric population.
Pajkrt E; van Lith JM; Mol BW; Bleker OP; Bilardo CM
Ultrasound Obstet Gynecol; 1998 Sep; 12(3):163-9. PubMed ID: 9793187
[TBL] [Abstract][Full Text] [Related]
4. Relationship between fetal nuchal translucency and crown-rump length in an Asian population.
Jou HJ; Wu SC; Li TC; Hsu HC; Tzeng CY; Hsieh FJ
Ultrasound Obstet Gynecol; 2001 Feb; 17(2):111-4. PubMed ID: 11251917
[TBL] [Abstract][Full Text] [Related]
5. If nuchal translucency screening is combined with first-trimester serum screening the need for fetal karyotyping decreases.
Marsk A; Grunewald C; Saltvedt S; Valentin L; Almström H
Acta Obstet Gynecol Scand; 2006; 85(5):534-8. PubMed ID: 16752230
[TBL] [Abstract][Full Text] [Related]
6. The influence of image magnification in first-trimester screening for Down syndrome by fetal nuchal translucency in Asians.
Hsu JJ; Chiang CH; Hsieh CC; Hsieh TT
Prenat Diagn; 2004 Dec; 24(12):1007-12. PubMed ID: 15614833
[TBL] [Abstract][Full Text] [Related]
7. First trimester nuchal translucency: effective routine screening for Down's syndrome.
Thilaganathan B; Sairam S; Michailidis G; Wathen NC
Br J Radiol; 1999 Oct; 72(862):946-8. PubMed ID: 10673944
[TBL] [Abstract][Full Text] [Related]
8. SURUSS in perspective.
Wald NJ; Rodeck C; Hackshaw AK; Rudnicka A
Semin Perinatol; 2005 Aug; 29(4):225-35. PubMed ID: 16104673
[TBL] [Abstract][Full Text] [Related]
9. Effect of first-trimester nuchal translucency on second-trimester maternal serum biochemical screening for Down's syndrome.
Thilaganathan B; Slack A; Wathen NC
Ultrasound Obstet Gynecol; 1997 Oct; 10(4):261-4. PubMed ID: 9383877
[TBL] [Abstract][Full Text] [Related]
10. Screening of maternal serum for fetal Down's syndrome in the first trimester.
Haddow JE; Palomaki GE; Knight GJ; Williams J; Miller WA; Johnson A
N Engl J Med; 1998 Apr; 338(14):955-61. PubMed ID: 9521983
[TBL] [Abstract][Full Text] [Related]
11. Down's syndrome screening with nuchal translucency at 12(+0)-14(+0) weeks and maternal serum markers at 14(+1)-17(+0) weeks: a prospective study.
Rozenberg P; Malagrida L; Cuckle H; Durand-Zaleski I; Nisand I; Audibert F; Benattar C; Tribalat S; Cartron M; Lemarié P; Stoessel J; Capolagui P; Jansé-Marec J; Barbier D; Allouch C; Perdu M; Roberto A; Lahna Z; Giudicelli Y; Ville Y
Hum Reprod; 2002 Apr; 17(4):1093-8. PubMed ID: 11925411
[TBL] [Abstract][Full Text] [Related]
12. SURUSS in perspective.
Wald NJ; Rodeck C; Hackshaw AK; Rudnicka A
BJOG; 2004 Jun; 111(6):521-31. PubMed ID: 15198778
[TBL] [Abstract][Full Text] [Related]
13. First-trimester screening for fetal aneuploidy: biochemistry and nuchal translucency.
Orlandi F; Damiani G; Hallahan TW; Krantz DA; Macri JN
Ultrasound Obstet Gynecol; 1997 Dec; 10(6):381-6. PubMed ID: 9476320
[TBL] [Abstract][Full Text] [Related]
14. [Screening for trisomy 21 by measuring nuchal translucency during the first trimester of pregnancy].
Charasson T; Ko-Kivok-Yun P; Martin F; Sarramon MF
J Gynecol Obstet Biol Reprod (Paris); 1997; 26(7):671-8. PubMed ID: 9471429
[TBL] [Abstract][Full Text] [Related]
15. First-trimester or second-trimester screening, or both, for Down's syndrome.
Malone FD; Canick JA; Ball RH; Nyberg DA; Comstock CH; Bukowski R; Berkowitz RL; Gross SJ; Dugoff L; Craigo SD; Timor-Tritsch IE; Carr SR; Wolfe HM; Dukes K; Bianchi DW; Rudnicka AR; Hackshaw AK; Lambert-Messerlian G; Wald NJ; D'Alton ME;
N Engl J Med; 2005 Nov; 353(19):2001-11. PubMed ID: 16282175
[TBL] [Abstract][Full Text] [Related]
16. Additional performance of nasal bone in first trimester screening.
Kozlowski P; Knippel AJ; Froehlich S; Stressig R
Ultraschall Med; 2006 Aug; 27(4):336-9. PubMed ID: 16596511
[TBL] [Abstract][Full Text] [Related]
17. The distribution of fetal nuchal translucency thickness in normal Korean fetuses.
Chung JH; Yang JH; Song MJ; Cho JY; Lee YH; Park SY; Moon MJ; Lim HJ; Choi JS; Kim JO; Shin JS; Ahn HK; Han JY; Kim MY; Choi KH; Ryu HM
J Korean Med Sci; 2004 Feb; 19(1):32-6. PubMed ID: 14966338
[TBL] [Abstract][Full Text] [Related]
18. Nuchal translucency measurement at different crown-rump lengths along the 10- to 14-week period for Down syndrome screening.
Zoppi MA; Ibba RM; Floris M; Manca F; Axiana C; Monni G
Prenat Diagn; 2005 May; 25(5):411-6. PubMed ID: 15906410
[TBL] [Abstract][Full Text] [Related]
19. Screening for Down's syndrome by fetal nuchal translucency measurement in a high-risk population.
Pajkrt E; Mol BW; van Lith JM; Bleker OP; Bilardo CM
Ultrasound Obstet Gynecol; 1998 Sep; 12(3):156-62. PubMed ID: 9793186
[TBL] [Abstract][Full Text] [Related]
20. The second-trimester fetal iliac angle as a sign of Down's syndrome.
Shipp TD; Bromley B; Lieberman E; Benacerraf BR
Ultrasound Obstet Gynecol; 1998 Jul; 12(1):15-8. PubMed ID: 9697278
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
